Addressing Anti-Competitive Health Care Contract Clauses Act
This bill mandates a study by the Government Accountability Office (GAO) to examine how specific contract clauses in health insurance agreements affect competition and costs. It focuses on "anti-steering" clauses (restricting insurers from directing patients to lower-cost providers), "anti-tiering" clauses (blocking tiered provider networks), "all-or-nothing" clauses (forcing inclusion of all providers), and "gag" clauses (preventing price transparency). The study will assess these clauses' impact on healthcare consolidation, consumer prices, access, and whether federal agencies have sufficient resources to enforce antitrust laws against them. The findings must be reported to relevant congressional committees within 18 months of the bill's enactment. This is a procedural study - no immediate policy changes are implemented by the bill itself.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2025
Committee Review
Floor Vote
President
Introduced Apr 24, 2025
Last action Apr 24, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Apr 24, 2025
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Apr 24, 2025
Introduced
Introduced in House
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Victoria Spartz
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 3020
Scope: US
Hi! I can help you understand HR 3020. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline